Brief: I-Mab Wei Fu, I-Mab’S Chairman Of Board, Appointed As Executive Chairman
08/09/2025 13:32
Sept 8 (Reuters) - I-Mab IMAB.O: I-MAB: WEI FU, I-MAB’S CHAIRMAN OF BOARD, APPOINTED AS EXECUTIVE CHAIRMAN I-MAB: PLANS GLOBAL PHASE 2 STUDY FOR GIVASTOMIG IN Q1 2026 Further company coverage: IMAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview